NM_000500.9:c.719T>A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 7P and 9B. PS3PM1PP2BP4_StrongBP6BS2

The NM_000500.9(CYP21A2):​c.719T>A​(p.Met240Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000878 in 1,613,904 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). ClinVar reports functional evidence for this variant: "SCV002598644: Experimental evidence evaluating an impact on protein function demonstrated this complex variant has no detectable enzymatic activity (Tusie-Luna_1990, Higashi_1991, Felix-Lopez_2003, Robins_2005).". Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M240T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0047 ( 8 hom., cov: 31)
Exomes 𝑓: 0.00048 ( 6 hom. )

Consequence

CYP21A2
NM_000500.9 missense

Scores

14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:3B:3

Conservation

PhyloP100: 0.343

Publications

41 publications found
Variant links:
Genes affected
CYP21A2 (HGNC:2600): (cytochrome P450 family 21 subfamily A member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
CYP21A2 Gene-Disease associations (from GenCC):
  • classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Laboratory for Molecular Medicine
  • classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV002598644: Experimental evidence evaluating an impact on protein function demonstrated this complex variant has no detectable enzymatic activity (Tusie-Luna_1990, Higashi_1991, Felix-Lopez_2003, Robins_2005).
PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 2 uncertain in NM_000500.9
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 52 curated pathogenic missense variants (we use a threshold of 10). The gene has 5 curated benign missense variants. Trascript score misZ: 1.8021 (below the threshold of 3.09). GenCC associations: The gene is linked to classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form.
BP4
Computational evidence support a benign effect (MetaRNN=0.054983348).
BP6
Variant 6-32039816-T-A is Benign according to our data. Variant chr6-32039816-T-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 242688.
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000500.9. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP21A2
NM_000500.9
MANE Select
c.719T>Ap.Met240Lys
missense
Exon 6 of 10NP_000491.4
CYP21A2
NM_001128590.4
c.629T>Ap.Met210Lys
missense
Exon 5 of 9NP_001122062.3P08686-2
CYP21A2
NM_001368143.2
c.314T>Ap.Met105Lys
missense
Exon 6 of 10NP_001355072.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP21A2
ENST00000644719.2
MANE Select
c.719T>Ap.Met240Lys
missense
Exon 6 of 10ENSP00000496625.1P08686-1
CYP21A2
ENST00000960600.1
c.719T>Ap.Met240Lys
missense
Exon 6 of 10ENSP00000630659.1
CYP21A2
ENST00000960597.1
c.719T>Ap.Met240Lys
missense
Exon 6 of 10ENSP00000630656.1

Frequencies

GnomAD3 genomes
AF:
0.00465
AC:
707
AN:
152162
Hom.:
8
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0158
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00190
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.000995
AC:
249
AN:
250242
AF XY:
0.000680
show subpopulations
Gnomad AFR exome
AF:
0.0128
Gnomad AMR exome
AF:
0.000840
Gnomad ASJ exome
AF:
0.0000995
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000796
Gnomad OTH exome
AF:
0.000327
GnomAD4 exome
AF:
0.000481
AC:
703
AN:
1461624
Hom.:
6
Cov.:
54
AF XY:
0.000413
AC XY:
300
AN XY:
727064
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0141
AC:
471
AN:
33462
American (AMR)
AF:
0.00132
AC:
59
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26132
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39692
South Asian (SAS)
AF:
0.000104
AC:
9
AN:
86198
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53404
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000818
AC:
91
AN:
1111874
Other (OTH)
AF:
0.00108
AC:
65
AN:
60388
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.374
Heterozygous variant carriers
0
49
99
148
198
247
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00469
AC:
714
AN:
152280
Hom.:
8
Cov.:
31
AF XY:
0.00447
AC XY:
333
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0160
AC:
663
AN:
41542
American (AMR)
AF:
0.00190
AC:
29
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68024
Other (OTH)
AF:
0.00568
AC:
12
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.406
Heterozygous variant carriers
0
30
60
89
119
149
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000306
Hom.:
0
ESP6500AA
AF:
0.0182
AC:
80
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00137
AC:
166

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY (3)
1
1
1
not provided (3)
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
11
DANN
Benign
0.88
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.0012
N
MetaRNN
Benign
0.055
T
MetaSVM
Benign
-1.1
T
PhyloP100
0.34
PrimateAI
Benign
0.30
T
PROVEAN
Benign
2.8
N
REVEL
Benign
0.18
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.14
MVP
0.76
MPC
0.72
ClinPred
0.0032
T
GERP RS
1.6
gMVP
0.48
Mutation Taster
=98/2
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6476; hg19: chr6-32007593; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.